Drimia calcarata
Drimia calcarata · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Drimia calcarata is a botanical species that has garnered significant scientific interest due to its potential medicinal properties. Recent research has focused on its specific anticancer activities against various malignant cell lines. Studies have demonstrated its efficacy in targeting both colorectal cancer and lung cancer cells. These therapeutic benefits are primarily investigated through the use of bulb extracts. Specifically, researchers utilize methanol and water extracts to evaluate the plant's bioactive compounds.
- Synonyms
- Urginea Calcarata · Ornithogalum Calcaratum · 1 more
- Common names
- Not available
- Family
- Asparagaceae
- Distribution
- Africa
- Plant Parts
- Not available
Classification
Common Names
Drimia calcarata is a distinctive plant species widely recognized by its common name, the Khoho Squill. This botanical specimen is often distinguished by its unique structural characteristics and its specific role within its natural habitat. Local traditions and regional knowledge frequently highlight the plant, reinforcing its identity as the Khoho Squill. Understanding its nomenclature helps researchers and enthusiasts alike navigate its classification more effectively. By studying this species, one gains a deeper appreciation for the diverse relationship between botanical naming and ecological identity.
Sources: Catalogue of Life (COL)
Synonyms
Drimia calcarata is a botanical subject frequently identified by several different names within scientific literature. Depending on the classification system used, it is often recognized by its synonym Geschollia calcarata. Researchers may also encounter this same species documented as Ornithogalum calcaratum in various taxonomic records. Additionally, the plant is widely known under the synonymous designation of Urginea calcarata. Understanding these overlapping names is essential for maintaining accuracy when studying its various biological relationships.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Drimia calcarata is a fascinating botanical specimen belonging to the kingdom Plantae. Within this vast kingdom, the plant is classified under the class Equisetopsida. It further resides in the order Asparagales, which defines many of its biological characteristics. This species is a distinguished member of the genus Drimia. Finally, its botanical lineage places it firmly within the family Asparagaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asparagales |
| Family | Asparagaceae |
| Genus | Drimia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Drimia calcarata is a distinct plant species primarily found throughout the vast continent of Africa. Its specific geographic range is concentrated within the southern reaches of the continent, particularly across the Cape Provinces. In addition to these coastal regions, the species thrives within the diverse landscapes of Southern Africa. Detailed observations also confirm its presence in the lush environments of KwaZulu-Natal. This distribution highlights the plant's ability to adapt to various regional climates within its natural habitat.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Drimia calcarata is a self-supporting herb characterized by its distinct growth form. This botanical species typically maintains a modest stature within its natural habitat. Depending on environmental conditions, its height generally ranges from a minimum of 0.07 m to a maximum of 0.44 m. Such compact dimensions make it a subtle yet resilient component of its ecosystem.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Drimia calcarata has demonstrated significant potential as a source of novel anticancer agents through recent scientific investigations. Studies on the plant's bulb extracts have revealed selective cytotoxicity against various human cancer cell lines, including colorectal and lung cancer cells. Research indicates that these extracts can induce programmed cell death, or apoptosis, by regulating key molecular pathways such as the STAT and p53 signaling systems. Notably, the extracts appear to target cancer cells effectively while maintaining safety profiles against non-cancerous cell lines. These findings suggest that D. calcarata could serve as a promising foundation for the development of new therapeutic strategies to combat chemoresistant malignancies.
Compounds
Drimia calcarata is a medicinal plant traditionally used by the Pedi people of South Africa to treat various ailments. Recent phytochemical analyses have revealed that the bulb extracts of this plant are rich in bioactive compounds. Specifically, the water extract of the plant contains significant amounts of flavonoids and tannins. These secondary metabolites contribute to the plant's high antioxidant activity and overall therapeutic potential. Such findings suggest that the presence of these compounds may play a vital role in the plant's ability to act as a potential anticancer agent.
Conditions
Drimia calcarata bulb extracts demonstrate significant anticancer potential by treating various cancer cell lines, including colorectal cancer. Specifically, the plant shows effectiveness in treating p53 mutant HT-29 colorectal cancer cells through the induction of apoptosis. In addition to its impact on colorectal malignancies, the plant is an effective agent for treating lung cancer. Research indicates that these extracts are particularly potent in treating mutant H1437 and mutant H1573 cell lines. These findings highlight the plant's ability to target diverse cancerous mutations through different molecular mechanisms.
Preparations
Drimia calcarata is prepared as bulb extracts to investigate its potential therapeutic applications. Specifically, these bulb extracts are prepared as methanol and water extracts for scientific evaluation. The methanol extract and water extract are utilized to test cytotoxicity against various colorectal and lung cancer cell lines. These specific preparations allow researchers to compare the phytochemical contents and antioxidant activities of the different mediums. Ultimately, the use of these methanol and water extracts helps identify the anticancer mechanisms within the plant.